April 17, 2017
The Japanese hemophilia drug market is projected to reach 69.2 billion yen in 2024, up 123.1% compared to 2015, according to market research firm Fuji Keizai. Fuji Keizai said in a report released on April 10 that recombinant preparations are...read more